Résultats de la recherche - 4 results
Release of Nano-objects, their aggregates and agglomerates from Masks: ambitions and scientific objectives of the RENAAME project
d’innovation mais est aussi source de préoccupation sanitaire en lien avec une possible exposition par inhalation aux nano-objets, leurs agrégats et agglomérats (NOAA). Ainsi, plusieurs produits commerciaux ...
The EMA PRIME procedure in an accelerated assessment environment for vaccine licensure: Experiences from quality (CMC) assessors. A case study for Ebola vaccine.
Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle; Koen Brusselmans Source: 2020 PDA EUROPE- Driving Biopharmaceutical Innovations & Sustainability ...
The ADVANCE Code of Conduct for collaborative vaccine studies.
sectors, concerns about possible or actual conflicts of interest (or perceptions thereof) and inadequate funding mechanisms. The Innovative Medicines Initiative’s Accelerated Development of VA ccine ...
Development and validation of a targeted LC-MS/MS quantitation method to monitor cell culture expression of tetanus neurotoxin during vaccine production
physical stress conditions applied during bacterial culture was also monitored. This work has been funded by the EU / EFPIA /Innovative Medicines Initiative 2 Joint Undertaking, termed the VAC2VAC project ...